The FDA approved the first drug from an emerging class of medicines for patients with a chronic, autoimmune kidney disease.
Major health insurers are taking drastic steps to discourage older adults from signing up for their private Medicare plans as ...
Like an estimated 20 million Americans, I have an incurable post-acute infection syndrome that goes by the name of long Covid ...
A next-generation treatment from Novo Nordisk helped patients with diabetes lower their blood sugar and lose weight in a ...
The lung cancer screening system “is not a risk assessment. It is a judgment system designed as one,” writes the director of ...
A federal commission is calling for significant changes to the way the U.S. government funds and assesses scientific research ...
The cat’s outta the bag: People are already using LLM-based chatbots like therapists whether it’s a good idea or not. Nevertheless, companies building customized therapy chabots must still convince ...
Novo Nordisk's blockbuster weight loss drug semaglutide failed to slow Alzheimer's progression in trials. The studies had ...
The Capitol Hill battle over hemp products underscores the concerns about the increasingly wild market and the widespread ...
Novo Nordisk’s weight loss drug semaglutide failed to slow the progression of Alzheimer’s disease in two large trials ...
STAT’s Eric Boodman visited Healthy Start case manager Malaika Milele Gardner in New Orleans recently, spending time with her ...
Friends…hello. I’m BACK. My wife and I welcomed a new baby a few months ago. We now have two kids (still weird to say kids, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback